14
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10320 |
Androgen receptor antagonist 1
|
Others | Others |
Androgen receptor antagonist 1 is an orally available full androgen receptor antagonist (IC50: 59 nM). It can be used in the synthesis of PROTAC AR degraders, which results in 24% and 47 % AR protein degradation in LNCaP cells at 1 μM and 10 μM, respectively. | |||
T10359 |
AR antagonist 1
|
Androgen Receptor; Ligand for E3 Ligase; Ligands for Target Protein for PROTAC | Endocrinology/Hormones; PROTAC |
AR antagonist 1 是 AR 拮抗剂,能够与 E3 连接酶配体结合,与 VHL 蛋白结合亲和力较弱,用于 PROTACARD-266 合成。 | |||
T6509 |
Galeterone
VN-124-1,TOK-001,VN/124-1,VN 124 |
P450; Androgen Receptor | Endocrinology/Hormones; Metabolism |
Galeterone (VN 124) 是CYP17抑制剂,能够多功能的抗雄激素,在去势抵抗性前列腺癌中,其IC50值为 47 nM。 | |||
T20625 |
Prochloraz
咪鲜胺,Sporgon,Prelude |
Estrogen Receptor/ERR; AhR; Androgen Receptor; Antifungal | Endocrinology/Hormones; Immunology/Inflammation; Metabolism; Microbiology/Virology |
Prochloraz (Prelude) 是咪唑类抗真菌剂。Prochloraz 抑制羊毛甾醇的细胞色素 P450 依赖性 14α-脱甲基作用,由此抑制麦角固醇的生物合成,从而导致真菌细胞膜破裂和细胞死亡。它也是雌激素受体和 雄激素受体的拮抗剂,IC50分别为25 μM 和4 μM, 并激活芳烃受体,EC50为1μM。 | |||
T9179 |
CLP-3094
2-([2-(4-CHLOROPHENOXY)ETHYL]THIO)-1H-BE |
Androgen Receptor | Endocrinology/Hormones |
CLP-3094 (2-([2-(4-CHLOROPHENOXY)ETHYL]THIO)-1H-BE) 是一种雄激素受体 BF3(binding function 3) 抑制剂,是一种选择性GPR142拮抗剂。BF3-IN-1 抑制 AR 转录活性 (IC50:4 μM)。 | |||
T13273 |
UT-34
|
Androgen Receptor | Endocrinology/Hormones |
UT-34 是选择性的、具有口服活性的泛雄激素受体拮抗剂和降解剂,能够作用于野生型 AR (IC50:211.7 nM)、F876L-AR (IC50:262.4 nM)、W741L-AR (IC50:215.7 nM)。它与配体结合结构域和功能 1结构域结合,并需要泛素蛋白酶体途径来降解AR。它有抗前列腺癌的能力。 | |||
T60988 |
Androgen receptor antagonist 4
|
||
Androgen receptor antagonist 4 (Compound AT2) 表现出抗癌活性。Androgen receptor antagonist 4 有效拮抗 AR 的转录活性,抑制 AR 的下游靶基因,并阻断 DHT 诱导的 AR 核转位。它是雄激素受体 (AR) 的拮抗剂 (IC50 = 0.15 μM)。 | |||
T60987 |
Androgen receptor antagonist 3
|
||
Androgen receptor antagonist 3 (Compound C18) 具有抗癌活性。它是雄激素受体 (AR) 的拮抗剂 (IC50 = 2.4 μM)。 | |||
T83119 |
Androgen receptor antagonist 9
|
Androgen Receptor | Endocrinology/Hormones |
安德罗根受体拮抗剂9(化合物28)作为雄激素受体的对抗物,阻断了该受体的活性。 | |||
T60719 |
AR antagonist 3
|
||
当 AR antagonist 3 显示出对肿瘤生长的有效抑制作用。AR antagonist 3 是雄激素受体 (AR)的选择性拮抗剂,IC50值为 0.47 μM。AR antagonist 3 以剂量依赖性的方式降低 FRET 信号 ,IC50值为 18.05 μM。 | |||
T78945 |
WCA-814
|
Androgen Receptor | Endocrinology/Hormones |
WCA-814是雄激素受体(AR)拮抗剂与Hsp90抑制剂的融合化合物,能够诱导全长AR及AR-V7降解,并展现出对前列腺癌细胞的细胞毒性(IC50: LNCaP细胞为171.2 nM,22Rv1细胞为26.5 nM)。 | |||
T79465 |
Anticancer agent 135
|
Androgen Receptor | Endocrinology/Hormones |
Anticanceragent 135(compound 26h)为一有效的雄激素受体(AR)拮抗剂,能够阻断AR核转位并抑制AR/AR-V7异二聚化,以抑制下游基因转录。该化合物在前列腺癌异种移植模型中展现出显著疗效。 | |||
T78811 |
PROTAC AR-NTD degrader 1
|
Androgen Receptor | Endocrinology/Hormones |
PROTACAR-NTD antagonist 1 (compound 18) 是一款针对雄激素受体AR-V7变体的PROTACs,它特异性地拮抗AR的N末端结构域 (AR-NTD),能有效诱导前列腺癌细胞凋亡,并在VCaP细胞中以1 μM 和 5 μM的浓度分别实现了62.2%和71.1%的AR-V7蛋白降解率。 | |||
T35855 |
AAA
|
||
AAA is an antagonist of G protein-coupled receptor 75 (GPR75).1It increases basal GPR75 protein levels and inhibits 20-HETE-induced reductions in GPR75 protein levels in PC3 cells. AAA (5 and 10 μM) also reduces 20-HETE-induced phosphorylation of EGFR, NF-κB, and Akt in, and cell migration of, PC3 cells.In vivo, AAA (10 mg/kg per day) reduces systolic blood pressure, albuminuria, renal angiotensin II levels, and cardiac hypertrophy in a Cyp1a1-Ren-2 transgenic rat model of malignant hypertension... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T75702 | Galloylalbiflorin | ||
Galloylalbiflorin (6′-O-Galloylalbiflorin) 为芍药根部提取的雄性激素受体 (AR) 拮抗剂,具IC50值为53.3 μM,展现抗雄激素活性。 |